The markers support non-invasive early detection, and may help reliably distinguish between healthy individuals and those with cervical cancer
A study from Sun Yat-sen University in Guangzhou shows: Combination of the biomarkers Apo10 and TKTL1 reliably detects early-stage breast cancer – and is able to distinguish between malignant and benign tumors.
A study conducted by Sun Yat-sen University in Guangzhou provides initial evidence that the biomarkers Apo10 and TKTL1 can help detect lung cancer at an early stage and distinguish it from benign pulmonary nodules.